Rocket Lab's Record Quarter Meets a Costly Reckoning

Record revenue and a $2.36 billion backlog offset a narrow earnings miss, as Rocket Lab races Neutron toward the pad while absorbing its $8 billion Iridium acquisition.

Key Takeaways

• Revenue rose 62 percent to a record $234.1 million, and backlog surged 137 percent to $2.36 billion, driven overwhelmingly by U.S. Space Force and defense contracting.
• The eight cent per share loss traced almost entirely to $8.6 million in acquisition costs; gross margin and Adjusted EBITDA both beat Rocket Lab’s own prior guidance.
• Rocket Lab is funding Neutron’s final stretch and an $8 billion Iridium deal largely with fresh equity, a bet that trades near term dilution for long term scale.

The Weight of a Record

Rocket Lab’s second quarter arrived dressed as an unambiguous triumph, and on the surface it was one. Revenue climbed 62 percent from a year earlier to $234.1 million, a fourth consecutive record and comfortably ahead of the roughly $231 million Wall Street had modeled. The growth was not cosmetic. Product revenue, the satellites and components business that increasingly defines the company’s identity, nearly doubled to $181.3 million, while service revenue, still anchored to launch, added a steadier $52.7 million. Sequential growth of nearly 17 percent lifted the top line $34 million above the prior quarter’s own record, a cadence Rocket Lab has now held for more than a year without interruption.

Yet the number that moved the stock told a different story. Net loss narrowed to $49.3 million, or eight cents a share, an improvement on last year’s thirteen cent loss but a cent or two wider than analysts had modeled. It would be a mistake to read that shortfall as a sign of operational strain. Chief Financial Officer Adam Spice traced the gap almost entirely to $8.6 million in transaction costs from the closed acquisitions of Mynaric and Motiv Space Systems and the pending purchase of Iridium Communications, expenses GAAP accounting forces the company to recognize immediately rather than spread across future periods. Remove that noise and the underlying quarter reads considerably better than the headline suggested, a distinction that mattered enormously to how the market ultimately absorbed the news.

Reading Between the Margins

On the metrics that actually measure operating discipline, Rocket Lab beat its own targets. GAAP gross margin reached 36.1 percent, above the company’s guided range of 33 to 35 percent, while the non-GAAP figure hit 41.5 percent against a 38 to 40 percent target. Adjusted EBITDA loss narrowed to $8.8 million, a sharp improvement from $27.6 million a year earlier and well inside management’s own guidance of a $20 million to $26 million loss. Gross profit nearly doubled to $84.6 million, helped by a favorable mix shift toward satellite platforms within Space Systems and an early, if modest, contribution from the newly folded in Mynaric business.

The balance sheet complicates that otherwise clean narrative. Non-GAAP free cash flow ran negative $110.1 million for the quarter, wider than the $77.4 million outflow in the first, as Neutron’s production ramp, inventory build and acquisition costs drained cash faster than the income statement was improving. Rocket Lab ended June with $2.13 billion in cash and cash equivalents, more than double where it stood at the close of 2025, but the increase traces almost entirely to a $1.53 billion at the market equity raise rather than the business generating cash on its own. Total stockholders’ equity nearly doubled to $3.49 billion. It is a company financing an aggressive expansion with fresh paper, a choice that has kept the balance sheet unusually well capitalized even as it dilutes existing holders, with the share count set to approach 641 million in the third quarter.

A Pipeline Built on Washington

If the income statement measured the quarter Rocket Lab just had, the backlog measured the one it is building toward. Total backlog reached $2.36 billion, up 137 percent from a year earlier, a figure driven overwhelmingly by government demand rather than commercial optimism. The largest single award, worth $397 million, came from the U.S. Space Force for Flatellite spacecraft supporting its Space Based Airborne Moving Target Indicator program, a mission to track airborne threats from orbit. Rocket Lab is one of only two contractors delivering combined launch and spacecraft solutions for that program, a distinction that reflects years of deliberate vertical integration rather than a fortunate contract win.

The rest of the quarter’s contracting told a similar story of institutional trust compounding. More than $160 million across two contracts will fund three geostationary satellites, including Rocket Lab’s first prime contract with the Space Force’s Space Systems Command for government owned GEO spacecraft, a genuine first for the company. Add more than $437 million in fresh launch contracts across Electron, HASTE and Neutron, pushing the launch backlog past ninety missions, and more than $1 billion in business already signed in the current quarter, and a clearer picture emerges. Government customers are no longer treating Rocket Lab as a promising startup to be evaluated mission by mission. They are treating it as infrastructure.

The Long Bet

Neutron remains the company’s defining wager, the vehicle on which its next competitive tier depends. Management reported more than 400 hot fires of the Archimedes engine, a full engine set now in production, and Stage 1 tank manufacturing tracking toward pad delivery in the fourth quarter. Spice was explicit that Rocket Lab intends to hold its $50 million to $55 million pricing for early flights rather than discount for volume, a stance that will face its real test only once the rocket has actually flown.

Layered atop that engineering risk is the far larger financial one, the roughly $8 billion agreement to acquire Iridium Communications, announced June 29. Iridium shareholders will receive $27 in cash plus Rocket Lab stock within a collar of $67.50 to $112.50, a structure valuing the deal at $54 a share, a 24 percent premium to Iridium’s prior close. A $3.6 billion bridge loan from Deutsche Bank and Wells Fargo will fund the cash portion, with closing targeted for mid-2027 pending regulatory and shareholder approval. Iridium brings a 66 satellite constellation, more than 2.5 million subscribers and roughly $871 million in annual revenue, the recurring cash flow Rocket Lab has never possessed. Peter Beck calls it the final piece of a self launching, vertically integrated space company. Skeptics would call it the most complicated integration Rocket Lab has ever attempted, arriving precisely as Neutron demands everything the company has.

What the Market Is Pricing In

Shares had already rallied roughly 41 percent in the two weeks before the report, a run built on contract headlines that raised the bar for what would count as a genuine beat. The stock closed the regular session down 3.4 percent at $80.04, then fell as much as 7 percent further after hours once the earnings miss crossed the tape, only to stabilize and recover through the following session as investors worked through the backlog and margin detail beneath the headline. By Tuesday, shares were back in the low to mid eighties, having essentially erased the initial decline, a pattern now familiar to anyone who has traded Rocket Lab through several of its recent reports.

Sell side sentiment going into the print remained decisively bullish, a Strong Buy consensus built on roughly thirteen to fourteen buy ratings against a handful of holds and a price target north of $110. Third quarter guidance points to yet another record, $250 million to $265 million in revenue, alongside an Adjusted EBITDA loss of $17 million to $23 million, though a GAAP gross margin guide of 29 to 31 percent signals some near term compression as Neutron and acquisition costs continue to ramp. The real question for Rocket Lab is no longer whether it can grow. The backlog has settled that argument. It is whether the company can convert that growth into cash before Neutron’s debut and the Iridium integration place simultaneous demands on a balance sheet that, for now, remains built on equity rather than earnings.